Work

Phase I trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A Children’s Oncology Group Study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.10036

Authors: Robin Elizabeth Norris, Elizabeth Fox, Joel M. Reid, Andrew T. Ralya, Xiaowei Liu, Charlotte H. Ahern, Charles Minard, Jodell Dahl, Rachel Eubank, Brenda Weigel

Institutions: Rainbow Babies & Children's Hospital, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Children's Oncology Group, Baylor College of Medicine, University of Minnesota, Children's National

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594904927

Cites:

Cited by: 3

Related to: 10